ECSP066758A - Nuevas combinaciones de un agente antiemetico y un inhibidor de encefalinasa - Google Patents

Nuevas combinaciones de un agente antiemetico y un inhibidor de encefalinasa

Info

Publication number
ECSP066758A
ECSP066758A EC2006006758A ECSP066758A ECSP066758A EC SP066758 A ECSP066758 A EC SP066758A EC 2006006758 A EC2006006758 A EC 2006006758A EC SP066758 A ECSP066758 A EC SP066758A EC SP066758 A ECSP066758 A EC SP066758A
Authority
EC
Ecuador
Prior art keywords
inhibitor
encephalinasa
new combinations
antiemetic agent
combinations
Prior art date
Application number
EC2006006758A
Other languages
English (en)
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP066758(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of ECSP066758A publication Critical patent/ECSP066758A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invención se refiere a nuevas combinaciones de un agente antiemético y un inhibidor de encefalinasa.
EC2006006758A 2004-02-12 2006-08-08 Nuevas combinaciones de un agente antiemetico y un inhibidor de encefalinasa ECSP066758A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04290384A EP1563848A1 (en) 2004-02-12 2004-02-12 New combinations of an anti-emetic agent and an enkephalinase inhibitor

Publications (1)

Publication Number Publication Date
ECSP066758A true ECSP066758A (es) 2006-11-24

Family

ID=34684783

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006758A ECSP066758A (es) 2004-02-12 2006-08-08 Nuevas combinaciones de un agente antiemetico y un inhibidor de encefalinasa

Country Status (28)

Country Link
US (1) US8222294B2 (es)
EP (2) EP1563848A1 (es)
JP (1) JP4987487B2 (es)
KR (1) KR101152308B1 (es)
CN (1) CN1917903B (es)
AT (1) ATE468138T1 (es)
AU (1) AU2005215262B2 (es)
BR (1) BRPI0506631B8 (es)
CA (1) CA2553827C (es)
CY (1) CY1110202T1 (es)
DE (1) DE602005021317D1 (es)
DK (1) DK1718337T3 (es)
EA (1) EA010625B1 (es)
EC (1) ECSP066758A (es)
ES (1) ES2344909T3 (es)
HR (1) HRP20100363T1 (es)
MA (1) MA28354A1 (es)
ME (1) ME01175B (es)
NO (1) NO337320B1 (es)
NZ (1) NZ548635A (es)
PL (1) PL1718337T3 (es)
PT (1) PT1718337E (es)
RS (1) RS51329B (es)
SI (1) SI1718337T1 (es)
TN (1) TNSN06246A1 (es)
UA (1) UA88156C2 (es)
WO (1) WO2005079850A1 (es)
ZA (1) ZA200605872B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
PT2866802T (pt) * 2012-06-28 2016-09-05 Johnson & Johnson Consumer Inc Composições líquidas racecadotril
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins

Also Published As

Publication number Publication date
ATE468138T1 (de) 2010-06-15
CY1110202T1 (el) 2015-01-14
EP1718337B1 (en) 2010-05-19
CA2553827A1 (en) 2005-09-01
EP1718337A1 (en) 2006-11-08
SI1718337T1 (sl) 2010-08-31
DE602005021317D1 (de) 2010-07-01
CN1917903B (zh) 2010-07-21
CN1917903A (zh) 2007-02-21
BRPI0506631B1 (pt) 2018-12-04
ZA200605872B (en) 2008-01-08
US20070275993A1 (en) 2007-11-29
US8222294B2 (en) 2012-07-17
BRPI0506631A (pt) 2007-05-08
JP2007522202A (ja) 2007-08-09
NZ548635A (en) 2009-10-30
KR20060132691A (ko) 2006-12-21
PL1718337T3 (pl) 2010-09-30
JP4987487B2 (ja) 2012-07-25
HRP20100363T1 (hr) 2010-07-31
RS51329B (en) 2011-02-28
EA200601466A1 (ru) 2006-12-29
ME01175B (me) 2013-03-20
EP1563848A1 (en) 2005-08-17
AU2005215262B2 (en) 2011-03-03
CA2553827C (en) 2012-08-07
MA28354A1 (fr) 2006-12-01
ES2344909T3 (es) 2010-09-09
UA88156C2 (ru) 2009-09-25
NO20063973L (no) 2006-09-05
NO337320B1 (no) 2016-03-07
PT1718337E (pt) 2010-06-16
EA010625B1 (ru) 2008-10-30
AU2005215262A1 (en) 2005-09-01
WO2005079850A1 (en) 2005-09-01
BRPI0506631B8 (pt) 2021-05-25
TNSN06246A1 (fr) 2007-12-03
DK1718337T3 (da) 2010-07-26
KR101152308B1 (ko) 2012-06-11

Similar Documents

Publication Publication Date Title
ECSP066758A (es) Nuevas combinaciones de un agente antiemetico y un inhibidor de encefalinasa
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
DK1847611T3 (da) Rhamnose-inducerbart ekspressionssystem
BRPI0515042A (pt) composição de tratamento para a lavagem de roupas, e, método de tratamento de um têxtil
NO20063147L (no) Antivirale farmasoytiske blandinger
NO20063624L (no) FC region varianter
TW200732349A (en) Anti-OX40L antibodies and methods using same
WO2005082341A3 (en) NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
ECSP056011A (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol
MX2008001597A (es) Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento.
DK1765953T3 (da) Kølemiddelsammensætning
PT1560812E (pt) Compostos de aminociclohexil eter e suas utilizacoes
AR034200A1 (es) Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
UY28344A1 (es) Nuevos compuestos
PT1118268E (pt) Metodo para a criopreservacao de esperma de peixe-zebra
MXPA05005484A (es) Metodo para mejorar las propiedaes fisico-quimicas de composiciones bituminosas y novedosas composiciones bituminosas con propiedades mejoradas y sus usos.
PT1322701E (pt) Composicao que retarda a pre-vulcanizacao
WO2004105696A3 (en) Combination therapy for the treatment of neoplasms
SE0302361D0 (sv) Inhibering av upptagning av monoamin
WO2003100030A3 (en) Kidney toxicity predictive genes
ATE546157T1 (de) Anti-pecam-therapie zur unterdrückung von metastasen
ATE339526T1 (de) Mittel zur entschwefelung von metallschmelzen
CY1115900T1 (el) Αντισωματα αντι-ephb4 και μεθοδοι χρησης αυτων
CY1112773T1 (el) Χημικες ενωσεις της 4-οξαδιαζολυλ-πιπεριδινης και χρησεις αυτων
UA2826U (uk) Спосіб лікування розсіяного склерозу